Women's Health
Explore Fortrea's research in women's health, focusing on innovative treatments and improving overall health outcomes.
Infectious Disease & Vaccines
Driving global success in infectious disease. Access Fortrea's global experience in viral, bacterial, fungal, and parasitic diseases and vaccine development.
Respiratory & Pulmonary Diseases
If you're pursuing a treatment compound or device for respiratory and lung diseases, Fortrea can give you access to preclinical pharmacological PD disease models, an extensive inhalation team and facility, and medical device development as well as clinical trials and post-market reimbursement strategies.
Ophthalmology
Advancing therapies with deep experience in front- and back-of-eye indications, cell and gene therapies, and specialized services to advance your ophthalmology clinical trial.
Obesity
Discover Fortrea's research efforts in obesity, focusing on weight management and innovative treatment approaches.
Neuroscience
Increase the likelihood of seamless trial conduct with Fortrea. Apply a science-driven approach to navigate the challenges of neuroscience clinical trials.
Nephrology
Through all clinical trial phases, let Fortrea be your trusted source for conducting renal studies. Our medical and operational experience encompasses a broad range of nephrology indications.
Hepatology
Optimize site selection and patient recruitment with our rich database of site-specific recruitment performance. Empower your liver disease clinical trials with our comprehensive medical, scientific and regulatory expertise.
Jill McConnell
Chief Financial Officer
Jill Gicking McConnell is the Chief Financial Officer of Fortrea (Nasdaq: FTRE). She has served in this position since Fortrea’s launch as an independent company in July 2023 following its spinoff from Labcorp (NYSE: LH).
Jill has more than 25 years of financial leadership in healthcare, driving growth and margin expansion as well as delivering global change and transformation projects while working in the U.S., U.K. and Ireland. Jill joined Labcorp as Chief Financial Officer of Labcorp Drug Development in 2018 until assuming the role at Fortrea. She most recently led the project that executed the spinoff of Fortrea from Labcorp. Previously, Jill held increasingly senior financial roles at GSK (LSE/NYSE: GSK), spanning the pharmaceutical lifecycle over almost 19 years. Her most recent position at GSK was Senior Vice President and Chief Financial Officer of ViiV Healthcare, a joint venture between GSK, Pfizer and Shionogi. Prior to GSK, Jill qualified as a Certified Public Accountant, primarily with PwC.
Jill has an MBA in Health and Medical Services Administration from Saint Joseph’s University and two bachelor’s degrees in Management and French from Gettysburg College. In addition to financial leadership, Jill is committed to employee engagement and has served as executive sponsor to several employee resource groups, both at Labcorp and GSK. In 2023, Jill was named as a Luminary by the Healthcare Businesswomen’s Association.
Georgina Strickland
Chief of Staff, Head of Strategy
Georgina Strickland is Chief of Staff and Head of Strategy at Fortrea, leading the development of corporate strategy. She has served in this position since Fortrea’s launch as an independent company in July 2023.
Georgina’s career in global drug development spans three decades. Prior to joining Labcorp, she served as Senior Vice President of Business Operations at Lightship, a clinical research organization, from 2020 to 2023. Previously, Georgina established and ran a program management office to mobilize enterprise-wide operational excellence at Parexel from 2017 to 2020. She held a variety of leadership roles at Quintiles, now part of IQVIA, over the course of 25 years. During her tenure she was Chief of Staff to the Chief Executive Officer and Vice President of Strategy, supporting the Quintiles and IMS merger, following roles in Corporate Development, Business Development and Operations.
Georgina earned her bachelor's degree in Biology at the University of Bristol in the U.K.